Janssen-Cilag International NV, part of Johnson & Johnson, has announced encouraging results from the phase 1b/2 OrigAMI-4 ...

"ESMO 2025: J&J eyes Rybrevant indication expansion to HNSCC on Phase II victory" was originally created and published by ...

Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients[i] New findings from this investigational study build on the strength of the data for amivantamab in ...

A novel therapy called amivantamab has shown early signs of effectiveness in treating advanced head and neck cancer, offering hope for patients with limited options.The drug targets two cancer growth ...

Investing.com -- Genmab A/S (CSE:GMAB) shares fell more than 3% on Monday after new data from Johnson & Johnson ’s amivantamab suggested the drug could rival Genmab and Merus N.V. ’s petosemtamab in ...

Responses were rapid and durable, and tumor shrinkage was observed in 82 percent of patients New findings from this investigational study build on the strength ...

Former mayor Will Flanagan was stabbed on the afternoon of Monday, Oct. 20, according to Fall River police. Police said they ...

Now it’s up to you, the little green prince with a head like a sideways salami, to travel through time armed with your sticky ...

The new Wavelength Pro LED Mask has five functions that treat the face, neck, back and the scalp. Each treatment takes 12 to ...

1. A rooftop bar or lookout point: Perfect for a golden-hour date, with a backdrop that does half the work for you. 2. An art ...

FOX47 News is helping inform you of the top local stories in your neighborhood. Happening Today helps neighbors know what is ...

The brand's new Head of Design discusses the newness she's bringing to the table, while still honoring the label's ...